Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
02/10/202110:19AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
02/09/20214:21PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
02/08/20219:26AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IMGNImmunoGen Inc
02/04/20218:38AMEdgar (US Regulatory)Schedule 13gNASDAQ:IMGNImmunoGen Inc
02/01/20213:30PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
01/29/20213:01PMBusiness WireImmunoGen Announces Conference Call to Discuss Its 2020 Operating ResultsNASDAQ:IMGNImmunoGen Inc
01/29/20219:03AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
01/11/20213:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/11/20213:50PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IMGNImmunoGen Inc
01/11/20216:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
01/05/20218:00AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/05/20217:59AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/04/20214:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/04/20213:30PMBusiness WireImmunoGen Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
01/04/202110:16AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/04/202110:14AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
12/30/20203:30PMBusiness WireImmunoGen Announces Webcast of Presentation and Q&A at the 39th Annual J.P. Morgan Healthcare ConferenceNASDAQ:IMGNImmunoGen Inc
12/21/20203:59PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IMGNImmunoGen Inc
12/18/20204:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
12/18/20204:17PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:IMGNImmunoGen Inc
12/18/20203:46PMEdgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:IMGNImmunoGen Inc
12/18/20203:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
12/11/20203:41PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
12/07/20207:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
12/05/20202:01PMBusiness WireImmunoGen Presents Updated Findings from Phase 1/2 Study of IMGN632 in Blastic Plasmacytoid Dendritic Cell Neoplasm at ASH An...NASDAQ:IMGNImmunoGen Inc
12/01/20203:30PMBusiness WireImmunoGen Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
11/30/20203:30PMBusiness WireImmunoGen Announces Conference Call to Discuss Recent Updates for IMGN632 in Blastic Plasmacytoid Dendritic Cell Neoplasm & A...NASDAQ:IMGNImmunoGen Inc
11/18/20203:30PMBusiness WireImmunoGen Announces Webcasts of Presentations at Upcoming Virtual ConferencesNASDAQ:IMGNImmunoGen Inc
11/06/20205:54AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
11/06/20205:30AMBusiness WireImmunoGen Reports Recent Progress and Third Quarter 2020 Financial ResultsNASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN